A double-blind trial of depot corticosteroids in Behçet's syndrome

Rheumatology

Volumn 45, Issue 3, 2006, Pages 348-352

  Mat, C ^a   Yurdakul, S ^b,c   Uysal, S ^a   Gogus, F ^b   Ozyazgan, Y ^a   Uysal, O ^a   Fresko, I ^b   Yazici, H ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Beh et; Corticosteroids; Erythema nodosum; Genital ulcer; Therapy

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; CORTICOSTEROID; METHYLPREDNISOLONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; BEHCET DISEASE; BODY WEIGHT DISORDER; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; ERYTHEMA NODOSUM; FACE EDEMA; FATIGUE; FEMALE; FOLLICULITIS; GENITAL ULCER; HUMAN; HYPERTRICHOSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SKIN DISEASE;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; BEHCET SYNDROME; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ERYTHEMA NODOSUM; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; METHYLPREDNISOLONE; MIDDLE AGED; ORAL ULCER; TREATMENT OUTCOME; ULCER;

EID: 33644871933     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei165     Document Type: Article

References (11)

1. Yazici H, Yurdakul S, Fresko I. Behcet's syndrome. In: Isenberg DA, Maddison PJ, Woo P, Glass DN, Breedveld FC, (eds). Oxford Textbook of Rheumatology. 3rd edn. Oxford: Oxford University Press, 2004:988-93.
2. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med 1999;341:1284-91.
3. Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease. Lancet 1989;1:1093-6.
4. Yazici H, Pazarli H, Barnes CG et al. A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med 1990;322:281-5.
5. Hamuryudan V, Mat MC, Saip S et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet's syndrome. Ann Intern Med 1998;128:443-50.
6. Yurdakul S, Mat C, Tüzün Y et al. A double blind study of colchicine in Behcet's syndrome. Arthritis Rheum 2001;44:2686-92.
7. Alpsoy E, Durusoy C, Yilmaz E et al. Interferon alfa-2a in the treatment of Behcet disease: A randomized, placebo controlled and double blind study. Arch Dermatol 2002;138:467-71.
8. Sharquie KE, Najim RA, Abu-Raghif AR. Dapsone in Behcet's disease: A double blind, placebo controlled, cross-over study. J Dermatol 2002;29:267-79.
9. International Study Group for Behçet's Disease. Criteria for diagnosis of Behcet's disease. Lancet 1990;335:1078-80.
10. Yazici H, Tüzün Y, Pazarli H et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome. Ann Rheum Dis 1984;43:783-9.
11. Ehrlich GE. Behcet disease and the emergence of thalidomide. Ann Intern Med 1998;128:494-5.